Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8678)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 27, 2022 (publication date) through Mar 29, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Colosimo S, Tomlinson JW. Bile acids as drivers and biomarkers of hepatocellular carcinoma. World J Hepatol 2022; 14(9): 1730-1738 [PMID: 36185719 DOI: 10.4254/wjh.v14.i9.1730] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Colosimo S, Tomlinson JW. Bile acids as drivers and biomarkers of hepatocellular carcinoma. World J Hepatol 2022; 14(9): 1730-1738 [PMID: 36185719 DOI: 10.4254/wjh.v14.i9.1730] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i9/1730.htm |
| Number | Citing Articles |
| 1 |
Victor Uchenna Chigozie, Charles Okechukwu Esimone. Engineering microbial metabolites to modulate tumor immunity and advance cancer immunotherapy. Discover Immunity 2026; 3(1) doi: 10.1007/s44368-026-00019-w
|
| 2 |
Zachary Detwiler, Snehal N. Chaudhari. BAAT away liver cancer: conjugated bile acids impair T cell function in hepatocellular carcinoma immunotherapy. Immunometabolism 2025; 7(2): e00062 doi: 10.1097/IN9.0000000000000062
|
| 3 |
Liting Chen, Eric Duran, Diego Headrick, Cheng Ji. Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes. International Journal of Molecular Sciences 2026; 27(3): 1189 doi: 10.3390/ijms27031189
|
| 4 |
Mingxia Deng, Jing Liu, Li Zhang, Yichun Zhang, Haoyang Hu, Jinyao Dai, Shaohua Dong, Lushun Jiang, Shuaibing Ying, Zhijuan Zhang, Yujing Wang, Keer Zhu, Yunqing Qiu, Yan Lou. Glycodeoxycholic acid inhibits hepatocellular carcinoma by driving M1 polarization of macrophages via the S1PR2-NF-κB-NLRP3 pathway. JHEP Reports 2026; : 101780 doi: 10.1016/j.jhepr.2026.101780
|
| 5 |
Yang Jin, Xiaobo He, Yanfeng Wu. Gastrointestinal cancer: molecular pathogenesis and targeted therapy. Molecular Biomedicine 2025; 6(1) doi: 10.1186/s43556-025-00361-9
|
| 6 |
Fang Zeng, Shi He, Ying Sun, Xue Li, Kaiyang Chen, Hongbin Wang, Shuli Man, Fuping Lu. Abnormal enterohepatic circulation of bile acids caused by fructooligosaccharide supplementation along with a high-fat diet. Food & Function 2024; 15(23): 11432 doi: 10.1039/D4FO03353A
|
| 7 |
Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon. Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities. Pharmacological Reviews 2026; 78(2): 100120 doi: 10.1016/j.pharmr.2026.100120
|
| 8 |
Tadashi Takeuchi, Yumiko Nakanishi, Hiroshi Ohno. Microbial Metabolites and Gut Immunology.
Annual Review of Immunology
2024; 42(1): 153 doi: 10.1146/annurev-immunol-090222-102035
|
| 9 |
Maria J. Monte, Laura Fàbrega, Marta R. Romero, Alvaro G. Temprano, Neil Kaplowitz, Carmen Garcia-Ruiz, Jose J.G. Marin, Jose C. Fernandez-Checa. Bile acids in liver and gastrointestinal cancer. Seminars in Cancer Biology 2025; 116: 45 doi: 10.1016/j.semcancer.2025.09.002
|
| 10 |
Annarosa Floreani, Daniela Gabbia, Sara De Martin. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(4): 2194 doi: 10.3390/ijms25042194
|
| 11 |
Carol Bernstein, Harris Bernstein. The Causal Role of Bile Acids in Cancers of the Digestive System. Biomedicines 2026; 14(3): 598 doi: 10.3390/biomedicines14030598
|
| 12 |
Mobina Kouhzad, Friedrich Götz, Tahereh Navidifar, Elahe Taki, Mahsa Ghamari, Roghayeh Mohammadzadeh, Maryam Seyedolmohadesin, Narjess Bostanghadiri. Carcinogenic and anticancer activities of microbiota-derived secondary bile acids. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1514872
|
| 13 |
Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, Kin Lam Yu, Sj Shen, Amany Zekry. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2240031
|
| 14 |
Yael R. Nobel, Heekuk Park, Alice M. Tillman, Dwayne Seeram, Dalia H. Moallem, Anna Intara, Renu Nandakumar, Medini K. Annavajhala, Angela Gomez-Simmonds, Elizabeth C. Verna, Anne-Catrin Uhlemann. Fecal Microbiota and Bile Acid Profiles in Early-Stage Hepatocellular Carcinoma: A Matched Case-Control Study. Clinical and Translational Gastroenterology 2025; 16(12): e00928 doi: 10.14309/ctg.0000000000000928
|
| 15 |
Rui Sun, Xiaoru Wang, Jiayi Ma, Yuying Cai, Lei Li, Shanshan Wang. The Roles and Clinical Significance of Major Hepatic‐Derived Metabolites in Hepatocellular Carcinoma. Journal of Gastroenterology and Hepatology 2025; 40(10): 2435 doi: 10.1111/jgh.70008
|
| 16 |
Hashem B. El-Serag, Aaron P. Thrift, Hao Duong, Jing Ning, Saira Khaderi, Amit G. Singal, Sumeet K. Asrani, Jorge A. Marrero, Hannah Powell, Kinza Rizwan, Omar Najjar, Christopher I. Amos, Michelle Luster, Abeer Al-Sarraj, Emad Salem, Michael E. Scheurer, Jagpreet Chhatwal, Salma Kaochar, Fasiha Kanwal. Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatology Communications 2024; 8(11) doi: 10.1097/HC9.0000000000000545
|
| 17 |
Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira Gohara, Ramakumar Tummala, Stanislaw Stepkowski, Amit K. Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz, Matam Vijay-Kumar. Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000166
|
| 18 |
Celine Oanes, Marina Alexeeva, Kjetil Søreide, Cato Brede. Salting-out assisted liquid-liquid extraction for UPLC-MS/MS determination of bile acids and kynurenine-, indole- and serotonin-pathway metabolites of tryptophan in human serum of healthy probands. Journal of Chromatography B 2025; 1255: 124519 doi: 10.1016/j.jchromb.2025.124519
|
| 19 |
Arick C. Park, Joel D. Schilling. The Cardiohepatic Axis in Heart Failure. JACC: Basic to Translational Science 2025; 10(7): 101312 doi: 10.1016/j.jacbts.2025.05.007
|
| 20 |
Yukai Chen, Shishi Zou, Le Xu, Jiayu Chen, Ling Wang, Yang Shen, Yangtao Xu, Yuxin Wei, Ximing Xu. NSMCE2 promotes the occurrence and development of HCC by regulating the SUMOylation of PPARα. International Immunopharmacology 2025; 157: 114762 doi: 10.1016/j.intimp.2025.114762
|
| 21 |
Dan Pan, Yiwen Bao, Xiaoping Lu, Qiqun Gu, Yongchao Zhang, Yi Zheng. Short‑chain fatty acids regulate hepatocellular carcinoma progression: A metabolic perspective on tumor immunity (Review). International Journal of Molecular Medicine 2025; 56(6): 1 doi: 10.3892/ijmm.2025.5655
|
| 22 |
Sijia Dai, Jingfei Zhu, Xuqiong Chen, Liming Zheng, Xiaoping Li, Longgen Liu. Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC–MS/MS. Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05686-6
|
| 23 |
Pau Pérez Escriva, Catarina Correia Tavares Bernardino, Elisabeth Letellier. De-coding the complex role of microbial metabolites in cancer. Cell Reports 2025; 44(3): 115358 doi: 10.1016/j.celrep.2025.115358
|
| 24 |
Maosen Xu, Yu Zhang, Yan Tie, Yiqiao Luo, Yang Wang, Ziqi Zhang. The role of bile acid metabolism-related genes in prognosis assessment of hepatocellular carcinoma and identification of NPC1 as a biomarker. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1588529
|
| 25 |
Zhi-Bo Yan, Cheng-Long Han, Ji-Sen Jia, Han Li, Dong-Hai Lu, Qi-Hang Cao, Yu-Xuan Wang, Ke-Fan Jiao, Qiao He, Sheng-Xuan Peng, Dao-Lin Zhang, Qiang Wang, Tao Li. The landscape of gut microbiota in hepatocarcinogenesis: a comprehensive review of pathogenesis and therapeutic interventions. International Journal of Surgery 2026; 112(1): 1673 doi: 10.1097/JS9.0000000000003511
|
| 26 |
Hang Yang, Tingting Yang, Jiaxin Ding, Xue Wang, Xi Chen, Jia Liu, Ting Shu, Ziteng Wu, Lixin Sun, Xin Huang, Zhenzhou Jiang, Luyong Zhang. Taurocholic acid represents an earlier and more sensitive biomarker and promotes cholestatic hepatotoxicity in ANIT‐treated rats. Journal of Applied Toxicology 2024; 44(11): 1742 doi: 10.1002/jat.4669
|
| 27 |
Hongyan Gou, Ruijie Zeng, Harry Cheuk Hay Lau, Jun Yu. Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer. Pharmacological Research 2024; 208: 107373 doi: 10.1016/j.phrs.2024.107373
|
| 28 |
Angela E. Dean, Douglas V. Guzior, Robert A. Quinn, Christoper A. Gaulke, Sayeepriyadarshini Anakk. Serum cholic acid and cecal Faecalibaculum increase in a male-specific manner in a murine hepatocellular carcinoma model. Journal of Lipid Research 2026; 67(1): 100954 doi: 10.1016/j.jlr.2025.100954
|
| 29 |
Blessy Kiruba, P. S. Athul Narayan, Badhari Raj, S. Rohieth Raj, Sam George Mathew, Sudhakaran Sajitha Lulu, Vino Sundararajan. Intervention of machine learning in bladder cancer research using multi-omics datasets: systematic review on biomarker identification. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02734-6
|
| 30 |
Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Giuseppina Martinelli, Pierluigi Federico, Simone Olivieri, Patrizia Iodice, Alessandro Federico. The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications. Journal of Personalized Medicine 2025; 15(4): 124 doi: 10.3390/jpm15040124
|
| 31 |
Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano. Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites 2024; 14(9): 513 doi: 10.3390/metabo14090513
|
| 32 |
Jianfeng Xu, Jian Sui, Da Xu, Xiaoxue Zhou, Youhong Hu, Jie Yuan, Jia Liu, Lu Lu. Single-Section Sequential MALDI-MSI Reveals Metabolic and N-Glycan Remodeling During Malignant Transformation in Hepatocellular Adenoma. Metabolites 2026; 16(4): 217 doi: 10.3390/metabo16040217
|